In 1963, Liddle et al. (1963) described a familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Similar cases have subsequently been reported (Aarskog et al., 1967; Milora et al., 1967) .
Liddle originally assumed the features of this condition to be due to a defect of the kidney to conserve sodium and excrete potassium in distal tubule. However, there are many problems about the pathophysiology remaining unsolved because of few cases reported. We here report a patient whose characteristic symptoms suggested a case similar to that described by Liddle et al. Case Report A 23-yr-old Japanese woman was referred to our clinic on July 1, 1980, in order to examine the cause of her hypertension.
She had been diagnosed as hypertensive for 10 years. In 1974, she had been admitted to another hospital with a presumptive diagnosis of primary aldosteronism because of marked hypokalemia with hypertension.
However, biochemical results for endocrine studies had revealed no positive findings for hyperaldosteronism.
Since then, the hypertension was controlled by treatment with thiazide diuretic with possium supplement and mild restriction of salt intake. There was nothing in her family history to et al. provement in blood pressure and led to a decrease in urinary potassium and a rise in serum potassium except during the period of potassium supplement therapy. Intramuscular injection of ACTH-Z (1 mg, daily) for 3 days caused a gradual rise in blood pressure. Oral administrations of dexamethasone, spironolactone and furosemide did not improve her blood pressure.
Discussion
Characteristic symptoms and laboratory findings including hypertension, hypokalemic alkalosis and decreased aldosterone values with suppressed renin in the present patient suggested strongly the possibility of Liddle's syndrome. Furthermore, the lack of therapeutic responses to spironolactone or dexamethasone accompanied with a good response to triamterene confirmed this diagnosis. Familial occurrence has usually been observed in Liddle's syndrome (Liddle et Vol.28, No.3 LIDDLE'S SYNDROME 361 al., 1963; Gardner et al., 1971; Ohno et al., 1973; Matsui et al., 1976 ), while we were not able to find a patient with hypertension in her pedigree. Sporadic cases have also been reported (Aarskog et al., 1967; Takahashi et al., 1979) . Hyporeninemic hypoaldosteronism was shown in our patient. However, PRA and aldosterone were increased by sodium restriction and the administration of triamterene and thiazide. Aldosterone also increased in the maximal stimulation by ACTH-Z. From these results, a primary defect of renin production in juxtaglomerular cells and of aldosterone synthesis in the adrenal cortex could be excluded.
Increased activity of mineralocorticoids except aldosterone may also induce similar clinical manifestation of this syndrome. In the present study, hypersecretion of deoxycorticosterone, corticosterone and cortisol were not demonstrated.
However, the overproduction of unusual mineralocorticoids is not negligible. Her hypertension and hypokalemia were not improved by spironolactone which is the specific antagonist of mineralocorticoid receptor. In addition, we could not demonstrate a sizeable tumor or enlarged glands in adrenal scintigram and computed axial tomography. These observations do not favor the presence of adrenal tumor at least more than 1 cm in diameter and unresponsiveness to spironolactone indicates that her hypertension and hypokalemia might not be the result of overactivity of mineralocorticoids. Margolius et al. (1974) have reported that urinary kallikrein excretion increases in normal subjects during a low sodium diet and in response to mineralocorticoid. Holland et al. (1980) also described that urinary kallikrein had to be elevated in some patients with primary aldosteronism and mineralocorticoid excess syndrome. These findings may lead to the use of the urinary kallikrein excretion rate as an index of mineralocorticoid activity. Levy et al. (1978) reported that an intravenous infusion of 5% glucose after sodium restriction increased urinary kallikrein activity in normal subjects. The basal level of urinary kallikrein after sodium restriction was low in our patient who did not show an increase following saline infusion, in comparison with patients with essential hypertension.
Although the mechanism regulating kallikrein excretion is still obscure, this may suggest that the overproduction of unusual mineralocorticoid do not exist in this patient.
A primary cause of Liddle's syndrome has been postulated to be a renal tubular abnormality with excess sodium conservation even in the virtual absence of mineralocorticoid. On the other hand, the presence of abnormal sodium transport in circulating erythrocytes in this syndrome has been shown by Helbock and Reynolds (1970) and Gardner et al. (1971) . Similar evidence has subsequently been reported by Hyman et al. (1979) . They suggested generalized membrane abnormality in sodium transport. However, there are few reports with regard to the site of a defect in renal tubules. In our patient, triamterene and thiazide alleviated her symptoms whereas furosemide did not. It is well known that triamterene acts on the distal renal tubular cells leading to a depression of the exchange of sodium for hydrogen and potassium ions and these actions are independent of mineralocorticoid.
Thiazide diuretic also acts on distal convoluted tubules to inhibit the reabsorption of sodium and its attendant anion. However, furosemide acts primarily to inhibit chloride and sodium reabsorption in the ascending limb of the loop of Henle with a minor effect on the distal tubule. From the facts described above, we concluded that the affected portion in the renal tubules in our patient is limited to the distal tubular cells dominating the state of sodium retention or the kaliuresis without mineralocorticoid action.
